Dr Christopher Earl Pelt, MD | |
590 S Wakara Way, Salt Lake City, UT 84108-1200 | |
(801) 587-7109 | |
Not Available |
Full Name | Dr Christopher Earl Pelt |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 19 Years |
Location | 590 S Wakara Way, Salt Lake City, Utah |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073653036 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 6353402-1205 (Utah) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Community Nursing Services | West valley city, UT | Home health agency |
University Of Utah Hospitals And Clinics | Salt lake city, UT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Utah Adult Services | 0941525273 | 1459 |
News Archive
Women's blood clot risk remains elevated for at least 12 weeks after delivering a baby - twice as long as previously recognized, according to a large study presented at the American Stroke Association's International Stroke Conference 2014.
Selexys Pharmaceuticals announced today that it has initiated enrollment in a Phase I clinical study of its lead compound, SelG1, a humanized anti-P-selectin antibody.
American and Italian researchers have found that a novel drug allows anandamide a marijuana like chemical in the body to effectively control pain at the site of an injury.
Bausch & Lomb today announced that the company's Lo-Torque- lens design demonstrates significantly better rotational recovery, which can lead to more consistent vision, compared with Acuvue's accelerated stabilization design. These findings from two clinical studies were presented at Academy 2009, the American Academy of Optometry annual meeting in Orlando, Fla.
› Verified 8 days ago
Entity Name | University Of Utah Adult Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683 |
News Archive
Women's blood clot risk remains elevated for at least 12 weeks after delivering a baby - twice as long as previously recognized, according to a large study presented at the American Stroke Association's International Stroke Conference 2014.
Selexys Pharmaceuticals announced today that it has initiated enrollment in a Phase I clinical study of its lead compound, SelG1, a humanized anti-P-selectin antibody.
American and Italian researchers have found that a novel drug allows anandamide a marijuana like chemical in the body to effectively control pain at the site of an injury.
Bausch & Lomb today announced that the company's Lo-Torque- lens design demonstrates significantly better rotational recovery, which can lead to more consistent vision, compared with Acuvue's accelerated stabilization design. These findings from two clinical studies were presented at Academy 2009, the American Academy of Optometry annual meeting in Orlando, Fla.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Christopher Earl Pelt, MD Po Box 413067, Salt Lake City, UT 84141-3067 Ph: (801) 581-3998 | Dr Christopher Earl Pelt, MD 590 S Wakara Way, Salt Lake City, UT 84108-1200 Ph: (801) 587-7109 |
News Archive
Women's blood clot risk remains elevated for at least 12 weeks after delivering a baby - twice as long as previously recognized, according to a large study presented at the American Stroke Association's International Stroke Conference 2014.
Selexys Pharmaceuticals announced today that it has initiated enrollment in a Phase I clinical study of its lead compound, SelG1, a humanized anti-P-selectin antibody.
American and Italian researchers have found that a novel drug allows anandamide a marijuana like chemical in the body to effectively control pain at the site of an injury.
Bausch & Lomb today announced that the company's Lo-Torque- lens design demonstrates significantly better rotational recovery, which can lead to more consistent vision, compared with Acuvue's accelerated stabilization design. These findings from two clinical studies were presented at Academy 2009, the American Academy of Optometry annual meeting in Orlando, Fla.
› Verified 8 days ago
Cameron R. Guy, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 590 S Wakara Way Rm A0058, Salt Lake City, UT 84108 Phone: 801-581-2121 | |
Benjamin Williams, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 82 S 1100 E Ste 303, Salt Lake City, UT 84102 Phone: 801-533-2002 Fax: 801-323-9546 | |
Chrystina James, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 590 S Wakara Way Rm A0058, Salt Lake City, UT 84108 Phone: 801-581-2121 | |
Thomas D. Bauman, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 333 S 900 E, Salt Lake City, UT 84102 Phone: 801-535-8163 Fax: 801-355-4011 | |
Jaclyn Aleksandra Konopka, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 590 S Wakara Way Rm A0058, Salt Lake City, UT 84108 Phone: 801-581-2121 | |
Jeffrey D Jackson, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1160 E 3900 S Ste 5000, Salt Lake City, UT 84124 Phone: 801-261-7479 Fax: 801-261-7429 | |
Dr. Enrique Feria-arias, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1160 E 3900 S Ste 5000, Salt Lake City, UT 84124 Phone: 801-261-7479 Fax: 801-261-7429 |